Pfizer

PFE

Healthcare

Global pharmaceutical company developing medicines, vaccines, and consumer healthcare products.

2 articles about Pfizer

The Charts That Explain Pfizer's Post-COVID Valuation Gap

At 9.6x forward earnings and a 6.3% dividend yield, Pfizer trades cheaper than every large-cap pharma peer while the base business — excluding COVID — has grown 29% since 2021.

Apr 10, 2026

Deep DivesPFE

Inside Pfizer's Oncology Pivot: Can the Pipeline Replace What COVID Took Away?

Pfizer's revenue has halved from its pandemic peak, but the oncology pipeline — anchored by a $43 billion Seagen acquisition — is the most ambitious portfolio rebuild in pharma history.

Apr 9, 2026